-
April 2, 2025
DeepSight's full presentation live from the Innovation Theatre at SIR 2025: "Breakthrough Imaging Technology for IR and IO: Redefining Device Tracking and Introducing Micro-Ultrasound on IR Devices".
-
March 4, 2025
DeepSight Technology, a leader in cutting-edge medical imaging solutions, is thrilled to announce the appointment of Dr. Alyssa Abo, MD, MBA as the company's new Vice President of Clinical Innovation. With over 20 years of experience at the intersection of medicine, technology, and business, Dr. Abo brings unparalleled expertise to DeepSight's leadership team.
-
January 14, 2025
DeepSight Technology, a leading innovator in medical device technology, today announced the appointment of Dr. Diku Mandavia as its new Chief Medical Officer (CMO). In this role, Dr. Mandavia will provide medical leadership across all clinical and commercial activities, guiding the development of DeepSight's cutting-edge ultrasound solutions, including NeedleVue™ Ultrasound System, OnPoint™ Imaging, and the EchoLux™ Ultrasound System.
-
November 26, 2024
DeepSight™ Technology, Inc., a pioneering force in medical imaging innovation, is thrilled to show its investigational NeedleVue™ LiteCart Ultrasound System at RSNA 2024, where it hopes to secure interest from clinicians who are interested in collaborating on clinical research to evaluate the device. NeedleVue aims to redefine ultrasound-guided interventional procedures, by addressing one of the most challenging aspects: clear and reliable visualization of needles, guidewires, and catheters. The device is being designed to provide real-time ultrasound visualization without the need for radiation or complex calibration. DeepSight's device aims to simplify and democratize procedures, enabling clinicians to perform interventions with confidence.
-
November 13, 2023
DeepSight™ Technology, a pioneering force in medical innovation, is thrilled to announce its groundbreaking NeedleVue™ solution. This state-of-the-art ultrasound-guided needle technology ushers in a new era of precision and safety in the field of directed interventional tool guidance, a domain grappling with complexities for several decades.
-
July 6, 2023
From fearlessly entering new fields of science to her passion for science fiction, Lan Yang (MS '00, PhD '05) loves exploring the unknown. Growing up in China, Yang was inspired by the life of Marie Curie, who's groundbreaking work altered medicine and our understanding of radioactivity.
-
January 13, 2022
John Chong, DeepSight Technology’s Head of Engineering and Product Strategy, was inducted into the SEMI-MSIG Hall of Fame for his renowned contributions to the MEMS & Sensors Industry Group.
The MEMS & Sensors Industry Group, a SEMI Strategic Association Partner, created the Hall of Fame in 2011 to honor those who have made a substantial and lasting impact to the industry. The Hall of Fame thanks industry leaders for inspiring in all of us that sense of mission, purpose, and dedication that drives this industry forward. John joins an impressive list of past inductees.
John’s career has been dedicated to bringing new technology to market and helping companies start, grow and scale. At DeepSight Technology, he works on the cutting edge of medical imaging using proprietary hardware, software and AI sensing technologies. These vastly improve image quality and extend the depth penetration of medical diagnostic ultrasound.
In addition, John advises on technology commercialization at Jib Technology and is active in SEMI’s MEMS and Sensors Industry Group, where he served as Chairman and now sits on the Governing Council.
Previous to DeepSight, John was VP of Product Strategy and Business Development at Kionix, a startup that grew to become a top-tier global manufacturer of sensors for consumer, automotive and industrial sectors. Prior to that he was Director of Engineering at Calient Networks, a leader in Photonics and Optical Networking. John holds a BS and Ph.D. from Cornell University, where he developed microfluidic lab-on-a-chip technology, is an inventor on numerous patents and has spoken at conferences worldwide about technology, market trends and company strategy.
-
October 11, 2021
DeepSight™ Technology has announced a $25 million Series A led by Deerfield Management Company, a healthcare investment firm, with additional funding from Wing, Alter Venture Partners, and Time BioVentures.
“We are excited to be on the frontier of advancing medical imaging,” said founder and CEO Nader Sadrzadeh. “Based on internal studies, our technology has the potential to achieve 100 times greater sensitivity, ultimately allowing us to deliver better patient care.”
DeepSight is augmenting diagnostic medical imaging with the introduction of novel ultrasound technology, using patented hardware, software, and AI algorithms to deliver 100 times higher sensitivity than other ultrasound systems in the market. Existing ultrasound technologies are limited by sensitivity, depth penetration and clarity. DeepSight improves ultrasound image quality and more than doubles the effective range when compared to conventional technologies.
“DeepSight Technology provides a potential platform opportunity to enhance non-invasive and invasive medical imaging for multiple diagnostic procedures, and in turn, improve the patient care process with more efficacious testing that costs less,” said Steven Hochberg, Partner at Deerfield. “We are pleased to be leading this Series A financing in a novel medical device technology which has the potential to help advance a range of imaging procedures.”